Literature DB >> 1648220

Rescue of a foreign gene by Sendai virus.

K H Park1, T Huang, F F Correia, M Krystal.   

Abstract

A simple protocol for the rescue of a synthetic genome into a paramyxovirus has been developed. First, a synthetic Sendai virus-like RNA, containing the antisense coding region of the chloramphenicol acetyltransferase gene replacing the coding region of the Sendai virus genome, was transcribed from a cDNA. When introduced into cells that are infected with Sendai virus, this RNA construct was transcribed, replicated, and packaged into infectious virions. The addition of infected cell extract to the RNA prior to transfection markedly enhanced levels of chloramphenicol acetyltransferase expression and rescue. However, this enhancement is not due to encapsidation of the RNA into nucleocapsids as the RNA remains nuclease-sensitive. Uninfected cell extract also enhances expression and rescue efficiency, implying involvement of a cellular factor(s) with the synthetic viral-like RNA construct that allows for enhanced polymerase recognition. This system should allow for the dissection of the various cis-acting RNA signals within the paramyxovirus genome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648220      PMCID: PMC51912          DOI: 10.1073/pnas.88.13.5537

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  20 in total

1.  Reovirus RNA is infectious.

Authors:  M R Roner; L A Sutphin; W K Joklik
Journal:  Virology       Date:  1990-12       Impact factor: 3.616

2.  In vitro assembly of infectious nucleocapsids of bacteriophage phi 6: formation of a recombinant double-stranded RNA virus.

Authors:  V M Olkkonen; P Gottlieb; J Strassman; X Y Qiao; D H Bamford; L Mindich
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  The cytoskeletal framework and poliovirus metabolism.

Authors:  R Lenk; S Penman
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

4.  Characterization of an in vitro system for the synthesis of mRNA from human parainfluenza virus type 3.

Authors:  B P De; M S Galinski; A K Banerjee
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

5.  Sendai virus DI RNA species with conserved virus genome termini and extensive internal deletions.

Authors:  L S Amesse; C L Pridgen; D W Kingsbury
Journal:  Virology       Date:  1982-04-15       Impact factor: 3.616

6.  Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs.

Authors:  A K Pattnaik; G W Wertz
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

7.  A minor microtubule-associated protein is responsible for the stimulation of vesicular stomatitis virus transcription in vitro.

Authors:  V M Hill; D F Summers
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

8.  Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.

Authors:  A K Pattnaik; G W Wertz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

9.  Complete sequences of the intergenic and mRNA start signals in the Sendai virus genome: homologies with the genome of vesicular stomatitis virus.

Authors:  K C Gupta; D W Kingsbury
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

10.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

View more
  49 in total

1.  Rescue of mumps virus from cDNA.

Authors:  D K Clarke; M S Sidhu; J E Johnson; S A Udem
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA.

Authors:  N Percy; W S Barclay; M Sullivan; J W Almond
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Ambisense gene expression from recombinant rabies virus: random packaging of positive- and negative-strand ribonucleoprotein complexes into rabies virions.

Authors:  S Finke; K K Conzelmann
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Rescue of synthetic analogs of respiratory syncytial virus genomic RNA and effect of truncations and mutations on the expression of a foreign reporter gene.

Authors:  P L Collins; M A Mink; D S Stec
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

Review 5.  Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited.

Authors:  D Kolakofsky; T Pelet; D Garcin; S Hausmann; J Curran; L Roux
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

Review 6.  Genetic engineering of animal RNA viruses.

Authors:  K K Conzelmann; G Meyers
Journal:  Trends Microbiol       Date:  1996-10       Impact factor: 17.079

Review 7.  Negative-strand RNA viruses: genetic engineering and applications.

Authors:  P Palese; H Zheng; O G Engelhardt; S Pleschka; A García-Sastre
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

8.  Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins.

Authors:  E A Stillman; J K Rose; M A Whitt
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV.

Authors:  Zhuhui Huang; Subbiah Elankumaran; Abdul S Yunus; Siba K Samal
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

10.  Recombinant vesicular stomatitis viruses from DNA.

Authors:  N D Lawson; E A Stillman; M A Whitt; J K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.